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Abstract
Background: To better understand the trends of behavioral and psychological symptoms of dementia (BPSD) over the disease progression is important to 
provide psychoeducation for dementia caregivers. Objective: This study examined the severity and occurrence of BPSD across the various degrees of the 
disease. Methods: This study was a cross-sectional design. Patients (N = 276) who had dementia from July 2001 to October 2008 were surveyed and assessed 
for dementia stage, using the clinical dementia rating scale (CDR). BPSD was evaluated using the Neuropsychiatric Inventory (NPI). We examined the 
differences between the severities and occurrence of the individual’s BPSD among various CDR stages with the Kruskal-Wallis test and Chi-square test. Results: 
Delusion (p = 0.01), agitation/aggression (p = 0.033), apathy/indifference (p = 0.009), aberrant motor behavior (p < 0.001), nighttime behavior disturbances 
(p < 0.001), and eating abnormalities (p = 0.001) were significantly different among stages of dementia. The severity of BPSD became exacerbated over the 
course of the disease, and was highest in moderate (CDR = 2) or severe (CDR = 3) dementia. The occurrence of BPSD was highest when the CDR equaled 2 
(97.5%). Discussion: The association of global (or certain) BPSD, across different stages of dementia, is a non-linear relationship. These findings suggest the 
importance of taking into account clinical dementia stage for managing BPSD.
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Introduction
The behavioral and psychological symptoms of dementia (BPSD) 
are common and serious problems that affect the quality of life for 
both patients with these symptoms, as well as their caregivers. BPSD 
present a major challenge in the medical management of patients, 
and are the major cause of institutionalization. After the onset of 
disease, more than 80% of demented patients exhibit at least one 
behavioral and psychological symptom, and no significant differences 
are observed in the prevalence between Alzheimer’s disease (AD) and 
non-AD dementias1. Among the factors associated with caregiver 
distress, the patient’s BPSD are most closely associated with caregiver 
burden2. Therefore, to better understand the trends of symptoms over 
the disease progression is important to provide psychoeducation for 
dementia caregivers in clinical practice.
The Neuropsychiatric Inventory (NPI)3 was developed to assess 
psychopathology in dementia patients, and has been widely used 
in studies for dementia. It evaluates 12 BPSD, including delusions, 
hallucinations, agitation/aggression, dysphoria/depression, anxiety, 
euphoria/elation, apathy/indifference, disinhibition, irritability/
lability, aberrant motor behavior, nighttime behavioral disturbances, 
and appetite and eating abnormalities. Many studies have investigated 
the prevalence of various BPSD as the dementia disorder progresses, 
using NPI. Apathy has seemed to become increasingly common as 
the dementia worsens4. Aggressive behavior and aberrant motor 
behavior have also been found to correlate with an increase in 
cognitive impairment5. Conversely, some studies have found a 
reduction of such behavior in the most severe stages6. There is no 
general agreement concerning hallucinations about whether there is 
a relationship between the level of cognitive impairment and BPSD4 
or not5,7. The studies on depressive symptoms in dementia have 
shown heterogeneous results. Some studies have found a decreased 
prevalence in severe dementia, while other studies have not found a 
association4,5,8. Some studies have found almost no correlation at all 
between BPSD and the level of cognitive impairment7,9.
In Taiwan, approximately 80% of the care for dementia patients 
is provided within the community by family members, and over 
half (56.6%) of main caregivers spend more than 8 hours per 
day caregiving10. Liu et al. reported a high prevalence of BPSD in 
Taiwanese patients with AD, and suggested that these symptoms 
were associated with cognitive deficits11. In a Taiwanese study, several 
clinical dementia stages10 and more behavioral disturbances12 were 
been reported to be the associative factors of caregiver burden. 
Huang et al.13 found that caregiver burden was significantly negatively 
correlated with CDR stages, and it was presumed that a patient with 
dementia was more difficult to take care of during the early and 
middle stage of disease, in which they had more BPSD. However, 
the investigation of the severity and prevalence of BPSD along the 
progression of the disease was scarce in Taiwan.
Our aim was to examine the severity and occurrence of BPSD 
across the different stages of the disease in Taiwan.
Methods
Subjects
This study used a cross-sectional design. In total, 276 patients with 
dementia who visited the memory clinic of a medical center in central 
Taiwan, from July 2001 to October 2008, were recruited. For the 
reliability of the data, we defined the criteria for dementia caregivers 
were (1) a relative (older than 18 years) who caring for the individual 
at least 4 hours per day; (2) being the primary caregiver and having 
intimate information of the patient over time. Subjects who fit the 
diagnostic criteria for dementia of the 4th edition of the Diagnostic 
and Statistical Manual of Mental Disorders14 were recruited and 
assessed for their stage of dementia, using the clinical dementia 
rating scale (CDR)15. If the CDR revealed a score of 0.5, we further 
confirmed the clinical history, educational level, as well as the Mini-
Mental State Examination (MMSE)16 scores to validate the diagnosis 
of dementia. The diagnosis was made by two senior physicians (W.F. 
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Wang and Y.C. Liao). The CDR, NPI, and cognitive functions test of 
all patients were assessed by well-trained and qualified psychologists. 
The hospital has a standardized objective, evidence-based procedure 
to authorize psychologists to provide clinical services consistent with 
their qualifications. The trained researchers verbally administered 
the instruments to the subjects and recorded the answers according 
to standardized procedure of each measurement. Caregivers’ 
backgrounds were collected at a single visit to the memory clinic. 
This study was conducted according to the Declaration of Helsinki, 
the regulation of clinical research in the country and was approved 
by the institutional review board of the medical center. Written 
informed consent was obtained from all subjects.
Measures
The patients’ BPSD were assessed using the NPI3, which was 
developed to measure psychopathology in people with dementia. 
The NPI includes 12 symptoms. The caregiver rated the frequency 
and severity of each symptom, using scores from 0 to 4 for frequency, 
and scores from 0 to 3 for severity. The NPI score for each BPSD 
was the product of the frequency and severity subscores (frequency 
multiplied by the severity). The total NPI score ranged from 0 to 
144. The Cronbach’s alpha coefficient of the Chinese version of the 
NPI was 0.76. The test-retest reliabilities of frequency and severity 
were significantly correlated, with the overall correlations being 0.85 
for frequency (p < 0.001), and 0.82 for severity (p < 0.001)17. The 
patients’ clinical dementia stages were assessed with the CDR, and 
cognitive function with the Chinese version of the cognitive abilities 
screening instrument (CASI, C-2.0)18. The MMSE score in this study 
was derived from part of the CASI score.
Data analysis
We used descriptive statistics to characterize the study population. 
Statistical analysis was performed using SPSS for Windows, version 
17.0 (SPSS Inc., Chicago, IL, USA). The assumption of a normal 
distribution of the variables was verified using the Kolmogorov–
Smirnov test, which showed a violation. Therefore, we used the 
non-parametric test to evaluate the data. In addition to descriptive 
statistics, the differences of severity of BPSD (the product score of 
the frequency multiplied by the severity subscores of individual 
BPSD domain) among dementia stages (different CDR stages) were 
tested using the Kruskal Wallis test. Furthermore, we examined the 
differences on the occurrence rate of BPSD among different stages 
of dementia with a Chi-square test. For all analyses, the probability 
level used to indicate statistical significance was set at p < 0.05.
Results
A total of 276 patients were recruited. The mean age was 79.70 ± 
7.20 years old. One hundred and eighty nine of 276 (68.5%) patients 
were female. The diagnosis of the patients comprised 167 cases of 
AD (60.5%), 70 cases of vascular dementia (25.4%), 25 cases of 
dementia due to multiple etiologies (9.0%), and 14 cases of dementia 
due to other general medical conditions (5.1%). Table 1 shows the 
characteristics of patients with dementia grouped by CDR in this 
study.
Table 2 lists the mean scores of the individual NPI domain, 
the product of the frequency and severity subscores (frequency 
multiplied by the severity), according to CDR stage in patients with 
dementia. The NPI total score resulted in a statistically significant 
difference among the different stages of dementia (p < 0.001), and 
scores were highest when the CDR equaled 3. By the individual 
NPI domain, delusion (p = 0.01), agitation/aggression (p = 0.033), 
apathy/indifference (p = 0.009), aberrant motor behavior (p < 0.001), 
nighttime behavior disturbances (p < 0.001), and appetite and eating 
abnormalities (p = 0.001) had statistically significant differences 
among the different stages of dementia. These BPSD became worse 
and worse over the disease course, and the product subscores were 
significantly higher in the moderate (CDR = 2) or severe (CDR = 3) 
stages, compared to the very mild (CDR = 0.5) stage of dementia.
Table 3 shows the percentage of the presence of each BPSD 
in different stages of dementia patients. The occurrence of BPSD 
(97.5%) was highest when the CDR equaled 2. There was a statistically 
significant difference in the occurrence rate among the stages of 
dementia. Considering each BPSD, the occurrence rate of delusion, 
apathy/indifference, aberrant motor behavior, nighttime behavior 
disturbances, and eating abnormalities was significantly different 
among the stages of dementia. The highest occurrence of delusion 
was 53.2% when the CDR equaled 2; apathy/indifference was 55.6%, 
when the CDR equaled 3; aberrant motor behavior was 48.1%, when 
the CDR equaled 3; nighttime behavior disturbances was 70.4%, 
when the CDR equaled 3; and appetite and eating abnormalities was 
41.8%, when the CDR equaled 2. In group 1 (CDR = 0.5), the highest 
occurring symptom was depression (40.0 %); in group 2 (CDR = 1), the 
highest occurring symptom was depression (47.2%); in group 3 (CDR 
= 2), the highest occurring symptoms were delusion and nighttime 
behavior disturbances (53.2%); in group 4 (CDR = 3), the highest 
occurring symptom was nighttime behavior disturbances (70.4%).
Discussion
Although the number of subjects was small in the later stage group 
of dementia (CDR = 4), we included the sample in the analysis in an 
attempt to illustrate the trend of severity and prevalence of BPSD, 
from very early to later stages of dementia. The results of this study 
revealed that severity of BPSD was associated with different stages 
in dementia. The highest severity of global BPSD was seen in severe 
dementia (CDR = 3), and decreased in severity when CDR equaled 
4. Considering individual BPSD, delusion, agitation/aggression, 
apathy/indifference, aberrant motor behavior, nighttime behavior 
disturbances, and appetite and eating abnormalities were significantly 
different among stages of dementia. The highest severity of the above 
symptoms was seen at the moderate (CDR = 2) or severe (CDR = 
3) stage of dementia. The occurrence of BPSD was highest at the 
moderate stage of dementia (CDR = 2). By each BPSD, the occurrence 
rate of delusion, apathy/indifference, aberrant motor behavior, 
nighttime behavior disturbances, and eating abnormalities were 
significantly different among the stages of dementia. The occurrence 
rate of these BPSD was highest at the moderate (CDR = 2) or severe 
stage (CDR = 3) of dementia.
The severity of some BPSD has demonstrated that they are 
associated with the dementia stages. Hashimoto et al.19 reported that 
seven of the 12 BPSD domains assessed by NPI revealed increased 
severity as dementia progressed. However, these results were only 
present for the patients in the very early stages (CDR = 0.5) to middle 
stages (CDR = 2) of dementia. The severity of seven BPSD domains 
included: delusion, hallucination, agitation, apathy, irritability, 
aberrant motor behavior, and sleep disturbance; and, all were highest 
at the moderate stage of dementia. These results did not find BPSD 
in later stages of dementia (CDR = 3 or 4). In the present study, the 
severity of delusion, agitation, apathy, aberrant motor behavior, 
nighttime behavior disturbances, and eating abnormalities were 
found to be statistically significantly different across the dementia 
stages. Indeed, as shown in Table 2, their NPI scores increased as 
the CDR progressed to the second stage. However, the severity of 
agitation and apathy continuously increased as the disease progressed 
to stage 4 of dementia. The severity of delusion was highest at stage 
2 of dementia, and gradually lessened afterward; the severity of 
aberrant motor behavior and nighttime behavior disturbances was 
highest at stage 3, and attenuated afterward. The longitudinal changes 
in symptom severity did not always result in a positive correlation 
with dementia severity, according to present study. 
Some studies suggested that there was no difference in prevalence 
of BPSD among the stages of dementia7,9. Our study found that the 
prevalence of delusion, apathy/indifference, aberrant motor behavior, 
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Table 1. Demographic and clinical characteristics of patients with dementia according to disease severity
CDR
All   P
0.5 1 2 3 4
N (%) 55 (19.9) 106 (38.4) 79 (28.6) 27 (9.8) 9 (3.3) 276 (100)
Age (years) 75.84 ± 6.27 79.57 ± 7.33 82.06 ± 6.56 80.96 ± 7.40 80.44 ± 7.11 79.70 ± 7.20 < 0.001a
Gender (female, %) 36 (65.5) 70 (66.0) 56 (70.9) 21 (77.8) 6 (66.7) 189 (68.5) 0.766b
Education (years) 4.71 ± 4.84 3.63 ± 4.17 3.08 ± 4.37 2.52 ± 3.79 1.33 ± 2.65 3.50 ± 4.34 0.066a
Diagnosis (AD, %) 43 (78.2) 62 (58.5) 42 (53.2) 15 (55.6) 5 (55.6) 167 (60.5) 0.049b
MMSE 20.17 ± 4.17 15.28 ± 4.57 10.07 ± 4.90 3.91 ± 3.32 1.40 ± 2.61 13.56 ± 6.69 < 0.001a
CASI 66.53 ± 17.13 48.63 ± 17.93 29.07 ± 16.54 15.20 ± 17.32 3.60 ± 10.47 41.96 ± 24.33 < 0.001a
a Analysis of variance (ANOVA); b Chi-square test; Values are n (%) or the mean ± SD.
CDR: Clinical Dementia Rating Scale; AD: Alzheimer’s Disease; MMSE: Mini-Mental State Examination; CASI: Cognitive Abilities Screening Instrument.
Table 2. Mean scores of individual NPI domains of the product subscores (frequency multiplied by the severity) according to dementia severity (CDR score), 
mean (SD)
CDR
All Pa Post hocb
0.5 1 2 3 4
Delusion 1.15 (2.67) 1.84 (3.31) 3.32 (4.12) 3.00 (3.75) 1.33 (4.00) 2.22 (3.59) 0.01 0.5 < 2; 0.5 < 3; 1 < 2; 2 > 4
Hallucination 0.67 (1.70) 1.02 (2.57) 1.90 (3.53) 2.41 (3.66) 2.00 (4.24) 1.37 (2.96) 0.051 0.5 < 2; 0.5 < 3; 1 < 3
Agitation/aggression 0.78 (2.32) 1.33 (2.70) 2.38 (3.55) 2.41 (3.51) 3.33 (5.29) 1.69 (3.14) 0.033 0.5 < 2; 0.5 < 3
Dysphoria/depression 1.44 (2.80) 2.07 (3.41) 2.56 (3.82) 1.41 (2.85) 0.44 (0.73) 1.96 (3.34) 0.245
Anxiety 1.05 (2.26) 1.63 (3.22) 2.42 (3.85) 2.59 (3.74) 1.44 (3.97) 1.83 (3.36) 0.455
Euphoria/elation 0.04 (0.19) 0.03 (0.17) 0.47 (1.82) 0.44 (2.31) 0 (0) 0.20 (1.23) 0.175 1 < 2
Apathy/indifference 1.18 (2.66) 1.70 (3.20) 2.53 (3.52) 3.52 (4.02) 4.00 (6.00) 2.09 (3.46) 0.009 0.5 < 2; 0.5 < 3; 1 < 3
Disinhibition 0.67 (2.08) 0.66 (2.08) 1.10 (2.68) 1.19 (2.40) 0.11 (0.33) 0.82 (2.27) 0.464
Irritability/Lability 1.22 (2.81) 1.80 (3.28) 2.32 (3.84) 2.89 (3.82) 2.67 (5.29) 1.97 (3.50) 0.361
Aberrant motor behavior 0.33 (1.26) 1.47 (3.19) 3.08 (4.28) 3.04 (3.93) 1.33 (3.04) 1.85 (3.50) < 0.001 0.5 < 1; 0.5 < 2; 0.5 < 3; 
1 < 2; 1 < 3
Nighttime behavior 
disturbances
1.36 (2.51) 1.98 (3.30) 3.63 (4.33) 5.56 (5.01) 3.33 (5.29) 2.72 (3.94) < 0.001 0.5 < 2; 0.5 < 3; 1 < 2; 1 < 3
Appetite and eating 
abnormalities
0.65 (1.80) 1.80 (3.43) 2.78 (4.00) 2.96 (4.09) 0 (0) 1.91 (3.47) 0.001 0.5 < 2; 0.5 < 3; 1 < 2; 
2 > 3; 2 > 4; 3 > 4
NPI total score 10.55 (13.70) 17.33 (20.42) 28.48 (21.75) 31.41 (17.82) 20.00 (16.87) 20.63 (20.55) < 0.001 0.5 < 1; 0.5 < 2; 0.5 < 3; 
1 < 2; 1 < 3
a P values refer to the Kruskal-Wallis test; b Comparison of NPI symptoms between different dementia stages. The column lists the CDR stages that have significant differences in NPI scores.
NPI: Neuropsychiatric Inventory; CDR: Clinical Dementia Rating Scale.















Delusion 15 (27.3) 37 (34.9) 42 (53.2) 14 (51.9) 1 (11.1) 109 (39.5) 0.004 0.5 < 2
Hallucination 11 (20.0) 26 (24.5) 28 (35.4) 12 (44.4) 2 (22.2) 79 (28.6) 0.086
Agitation/Aggression 10 (18.2) 31 (29.2) 31 (39.2) 11 (40.7) 3 (33.3) 86 (31.2) 0.089
Dysphoria/Depression 22 (40.0) 50 (47.2) 39 (49.4) 8 (29.6) 3 (33.3) 122 (44.2) 0.357
Anxiety 16 (29.1) 37 (34.9) 29 (36.7) 11 (40.7) 2 (22.2) 95 (34.4) 0.744
Euphoria/Elation 2 (3.6) 3 (2.8) 8 (10.1) 1 (3.7) 0 (0) 14 (5.2) 0.190
Apathy/Indifference 11 (20.0) 33 (31.1) 34 (43.0) 15 (55.6) 3 (33.3) 96 (34.8) 0.009 0.5 < 3
Disinhibition 9 (16.4) 18 (17.0) 17 (21.5) 8 (29.6) 1 (11.1) 53 (19.2) 0.530
Irritability/Lability 15 (27.3) 39 (36.8) 31 (39.2) 12 (44.4) 2 (22.2) 99 (35.9) 0.435
Aberrant motor behavior 6 (10.9) 29 (27.4) 34 (43.0) 13 (48.1) 2 (22.2) 84 (30.4) < 0.001 0.5 < 2; 0.5 < 3
Nighttime behavior 
disturbances
18 (32.7) 39 (36.8) 42 (53.2) 19 (70.4) 3 (33.3) 121 (43.8) 0.003 0.5 < 3; 1 < 3
Appetite and eating 
abnormalities
9 (16.4) 29 (27.4) 33 (41.8) 11 (40.7) 0 (0) 82 (29.7) 0.003 0.5 < 2
Any BPSD 41 (74.5) 90 (84.9) 77 (97.5) 26 (96.3) 7 (77.8) 234 (87.6) 0.001 0.5 < 2;
1 < 2
a P values refer to Chi-square test; b Post hoc analysis of comparison for each NPI symptoms between different dementia stage. The column lists the CDR stages that have significant differences; 
values are n (%).
CDR: Clinical Dementia Rating Scale.
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nighttime behavior disturbances, and eating abnormalities was 
significantly different among the stages of dementia. Using 10 items 
of the NPI, Piccininni et al.20 reported that only aberrant motor 
activity produced a statistically significant increase in NPI scores 
from a mild to severe degree of the disease; they also confirmed a 
clear trend of increased frequencies of disease severity in delusions 
and hallucinations. Symptoms of nighttime behavior disturbances 
and eating abnormalities were not mentioned in their study. These 
differing results, which may have been caused by both nighttime 
behavior disturbances and eating abnormalities, were not included in 
the 10-item NPI. Furthermore, in this study, hallucination symptoms 
occurred most frequently in those with severe dementia (CDR = 
3); the p value equaled 0.086. Although the NPI is the most widely 
used measurement for BPSD, it still retains some shortcomings. 
For instance, the NPI is based on caregiver’s observations that 
are obtained during a clinical interview, and does not allow for 
the clinician’s judgment to be factored into the assessment. Non-
professional caregivers may overlook some symptoms and signs of 
hallucinations or other BPSD. This may produce a bias in the study, 
and likely result in different findings between the current study and 
the others. 
Our findings on the prevalence of BPSD showed a significant 
difference between the various stages of dementia. In general, the 
highest rate of occurrence was noted in stage 2 or 3 of dementia, 
and the lowest rate of occurrence was seen in more severe stages of 
dementia. We suggested that the association of global (or certain) 
BPSD (concerning severity and prevalence), across different stages 
of dementia, is a non-linear relationship. This finding is consistent 
with the study of Lövheim et al.21, in which the correlation between 
some BPSD and the level of cognitive impairment was found to be 
significant and non-linear, and the highest prevalence rates occurred 
at the middle stages of dementia. Lövheim et al.21 confirmed that the 
factor of passiveness had an almost linear correlation to the level of 
cognitive impairment. The aggressive behavior, wandering behavior, 
restless behavior, verbally disruptive/attention-seeking behavior, 
regressive/inappropriate behavior, hallucinatory symptoms, and 
depressive symptoms had the highest prevalence of middle-stage 
dementia and non-linear correlation. The use of a different scale 
(the Multi-Dimensional Dementia Assessment Scale, MDDAS22) 
in Lövheim et al.’s study may offer new information, although it 
has limited comparability. In comparing the MDDAS with the 
NPI, passiveness may partly correspond to apathy; aggressive 
behavior corresponds to delusion, wandering and restless behaviors 
correspond to aberrant motor behavior; verbally disruptive/ 
attention-seeking behavior may partially correspond to nighttime 
behavior disturbances; and, some descriptions of restless behaviors 
may correspond to eating abnormalities in the NPI. In a similarity 
seen in both studies, some symptoms, like delusion, aberrant motor 
behavior, nighttime behavior disturbances, and eating abnormalities, 
showed the highest severity and occurrence when CDR was 2 or 3, 
and lessened at later stages of dementia. Divergently, and unlike 
Lövheim et al.’s results, we found that the prevalence of apathy was 
highest when CDR equaled 3, and it decreased at stage 4 of CDR. 
The occurrence rate of apathy did not show an increasing trend 
as dementia progressed. Because the subjects of the stage 4 group 
were few in number, statistical power may have been limited. The 
occurrence rates of depression and hallucinations were relatively 
stable and were not significantly different among the stages of 
dementia in our study. However, a slightly decreased occurrence rate 
was still noted for both symptoms at later stages of dementia. The 
relatively smaller sample size in stage 3 and 4 may have restricted 
the ability to generalize our results. Because of the patients’ reduced 
speech, communication ability, and motor function, caregivers may 
have had difficulty interpreting symptoms (such as delusion) in later 
stages of dementia. Furthermore, motor functions were affected, 
and this may have contributed to the reduced prevalence of certain 
behavioral disturbances, such as aberrant motor behavior, nighttime 
behavior disturbances, and eating abnormalities at that stage.
Our study identified a high frequency and severity of depression 
in the very early stage (CDR = 0.5) of dementia patients, similar 
to previous findings23. It is possible that symptoms are associated 
with pathological changes in regions of the brain associated with 
its pathogenesis. There is evidence of increased neuropathological 
changes within the hippocampus in AD patients who suffer from 
depression24. An alternative explanation is that depression in 
dementia patients is an emotional reaction to the decline of cognitive 
function in the early stage of dementia. People with memory 
problems have a high risk of psychological distress and depressive 
symptoms as a result of the situation25. Compared with the relatively 
stable prevalence and severity of depression and anxiety, there 
was a progressive prevalence of apathy, delusion, aberrant motor 
behavior, nighttime behavior disturbances, and eating abnormalities 
symptoms, from the very early to middle stages of dementia. For 
example, structural atrophy and functional deficits in medial and 
frontal regions associated with motivation and reward mechanisms 
of the brain may account for the increased prevalence of apathy as 
the disease progresses26. This is supported by previous results, in 
which apathy increased with increased severity of memory deficits27, 
or global cognitive impairment9.
This study had several limitations in terms of data generalization. 
First, because only the patients from community were recruited in this 
study, the difference between people accommodated from community 
and long-term institutions on the occurrence of BPSD28 could not be 
compared in this study. Second, we included subjects with AD and 
non-AD. We were unable to differentiate the effects between different 
dementia subtypes, which may have produced differential effects on 
BPSD; although, there was no significant difference in severity and 
prevalence between AD and non-AD dementias in some studies1,29. 
Third, nighttime behavior disturbances and eating abnormalities 
were not included in the 10-item NPI. The evaluation instrument that 
assessed BPSD restricted the generalization of results among studies. 
Fourth, the symptoms present in the patients tended to fluctuate; the 
probability that a person’s symptom occurred at certain time-point 
during the cognitive decline was probably higher. The prevalence 
rates were likely further affected by the fact that these BPSD may have 
been higher and more severe in a hospital-based study sample than a 
community population. Fifth, the relatively small sample size of the 
stage 4 dementia group may have limited the analysis and restricted 
the representativeness.
In summary, the severity and occurrence of BPSD are different 
in various stages of dementia. The highest severity of global BPSD 
occurred at the severe stage dementia (CDR = 3), and decreased at 
the later stage of dementia (CDR = 4). The severity and prevalence 
of delusion, apathy, aberrant motor behavior, nighttime behavior 
disturbances, and eating abnormalities were different among stages 
of dementia. The clinicians should take into account clinical dementia 
stage in managing BPSD and offering psychoeducation toward 
caregivers in clinical practice.
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